- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04887441
Allergology: Information, Data and Knowledge Organization (ALLERGIDOC)
Digital technology is essential in the field of health, via connected objects, the medical Internet or even telemedicine; and the info-communication practices (ways of getting information and communicating) of the actors go through digital devices. In addition, at present, the mass of activity documents to be managed in healthcare establishments and an abundant supply of documentary resources in health, available on the Internet, lead to infobesity, information pollution, and work overload. These phenomena lead to an increase in the time spent searching for relevant information and even to the burnout of healthcare professionals. A contextualization of the information communication systems through which the practices of health professionals pass therefore seems necessary so that the tools for managing, extracting and organizing knowledge can support these actors in their work.
In the field of allergies, there are many players, and the information that is useful to them is abundant and heterogeneous. This study is based on the hypothesis that a knowledge organization model, developed from existing practices, could make it possible to obtain satisfactory results when searching for information, and be integrated into the daily practices of actors by linking up with other already existing systems and tools.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Professionals from the Allergy Unit (doctors, interns, paramedics, study coordinators), in total around 20-30 people.
- Observations will be conducted during their team meetings and will not impact their workflow.
- Subjects publishing information on allergy on public web sites
Exclusion criteria:
- Professional not willing to participate to the research.
- Users publishing information on private web sites or forums.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the ontology model
Time Frame: 24 months
|
measure (a) the efficiency of the model developed in the target technology (technology-focused evaluation), (b) the satisfaction of the professionals of the unit (user-focused evaluation) and (c) we will evaluate its formalization by an expert in knowledge organization systems (ontology-focused evaluation).
The evaluations (a) and (b) will be made through the integration of the model into a future information communication device, and probably, into another existing device.
The task will consist, for example, in the search for information and documents necessary for the information activities of professionals.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment and validation of the model
Time Frame: 18 months
|
(a) At the end of the interrogation of a tool designed by professionals, we will calculate the recall rate, precision and F-measure.
The efficiency of the model will be considered satisfactory, if the result obtained is equal or superior to other projects (b) The organizational model assessment will engage 10 professionals from the allergology unit.
Professionals will assign (anonymously) the marks according to the level of satisfaction of the results of their request: 5 - Very satisfactory, 4 - Satisfactory, 3 - Fairly satisfactory, 2 - Unsatisfactory, 1 - Unsatisfactory.
(c) The model will also be evaluated by a knowledge organization systems expert, selected from members of the International Society for Knowledge Organization.
|
18 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL21_0253
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.